UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation

Yiannakou, Y., Agrawal, A., Allen, P.B. et al. (9 more authors) (2018) UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation. Therapeutic Advances in Gastroenterology, 11. ISSN 1756-283X

Abstract

Metadata

Authors/Creators:
  • Yiannakou, Y.
  • Agrawal, A.
  • Allen, P.B.
  • Arebi, N.
  • Brown, S.R.
  • Eugenicos, M.P.
  • Farmer, A.D.
  • McLain-Smith, S.
  • McLaughlin, J.
  • Sanders, D.S.
  • Lawrance, D.
  • Emmanuel, A.
Copyright, Publisher and Additional Information: © 2018 The Authors. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Keywords: irritable bowel syndrome with constipation; linaclotide; observational study
Dates:
  • Accepted: 25 July 2018
  • Published (online): 3 October 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 19 Nov 2019 13:21
Last Modified: 19 Nov 2019 13:21
Status: Published online
Publisher: SAGE Publications
Refereed: Yes
Identification Number: https://doi.org/10.1177/1756284818798791

Share / Export

Statistics